Gene Therapy Imperative Optimizes Manufacturing to Keep Pace with Market Development
With the proliferation of gene therapies and the demand for patient doses, the pressure on in-house and contract manufacturers is building.
Source: genengnews.com
Stay updated with breaking news from Unchained Lab Stunner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With the proliferation of gene therapies and the demand for patient doses, the pressure on in-house and contract manufacturers is building.
With the proliferation of gene therapies and the demand for patient doses, the pressure on in-house and contract manufacturers is building.